Their use for Alcohol Use Disorder (AUD) or drug addiction is considered "off-label." However, groundbreaking clinical research from 2025 and 2026 demonstrates that these medications significantly dampen the brain's reward centers, drastically curbing cravings for alcohol, opioids, and nicotine
In this case, their symptoms may be mild but noticeable and persistent, or they may have no symptoms at all
GLP-1 medications provide important safety information on their websites, including possible side effects from taking the drug
A similar share cite the drugs side effects (13%), while fewer say they stopped because their condition improved (5%)
Some patients also report feeling less emotionally reactive to things they usually enjoy, Corrado says, though more research is needed
Effect of Diet and Dietary Components on the Composition of the Gut Microbiota